Heart Disease News and Research

Latest Heart Disease News and Research

COVID-19 infection in pregnant women linked to increased risk of adverse outcomes

COVID-19 infection in pregnant women is associated with increased risk of adverse outcomes compared to women who are not pregnant, according to a review published in JACC: Advances from the American College of Cardiology Cardiovascular Disease in Women Committee.

11 Aug 2022

They call it ‘tranq’ — and it’s making street drugs even more dangerous

Approaching a van that distributes supplies for safer drug use in Greenfield, Massachusetts, a man named Kyle noticed an alert about xylazine.

11 Aug 2022

International medical experts aim to use biomarker-based approaches to advance precision medicine

The diagnostics company SphingoTec GmbH (SphingoTec), announces that, during the 4th Scientific Symposium held near Potsdam, Germany, international medical experts discussed the latest developments in diagnostic and therapeutic innovations for advancing precision medicine in critically ill patients.

11 Aug 2022

How ultraprocessed foods affect gut microbiome and health

Researchers describe the association between the consumption of ultraprocessed foods and chronic medical conditions.

10 Aug 2022

Older adults with atrial cardiopathy may have higher dementia risk

Older adults with atrial cardiopathy (a major, often undetected cardiac cause of stroke) may be at increased risk of developing dementia, according to new research led by Johns Hopkins Medicine.

10 Aug 2022

Scientists discover new target for treatment of premature aging disorders

A stretch of DNA that hops around the human genome plays a role in premature aging disorders, scientists at the Salk Institute and King Abdullah University of Science and Technology in Saudi Arabia have discovered.

10 Aug 2022

Leisure activities may help lower the risk of dementia

Leisure activities, such as reading a book, doing yoga and spending time with family and friends, may help lower the risk of dementia, according to a new meta-analysis published in the August 10, 2022, online issue of Neurology, the medical journal of the American Academy of Neurology.

10 Aug 2022

Abnormal size or functioning in the heart's left atrium may increase dementia risk

Structural or functional abnormalities within the heart's left atrium, with or without symptoms, may increase a person's risk of developing dementia later in life by 35%, according to new research published today in the Journal of the American Heart Association, an open access, peer-reviewed journal of the American Heart Association.

10 Aug 2022

Formulary restrictions may increase the risk of stroke in patients with atrial fibrillation

Atrial fibrillation (AF) is a major risk factor for stroke, and for decades the anticoagulant warfarin was the standard treatment for lowering that hazard. However, numerous drug and food interactions make warfarin burdensome for patients.

10 Aug 2022

How common is chronic fatigue syndrome among patients with long COVID-19?

In a new study, researchers found that myalgic encephalitis/chronic fatigue syndrome (ME/CFS) was common in long COVID-19.

10 Aug 2022

Study explores the role of follicle stimulating hormone in driving postmenopausal obesity, breast cancer

For women approaching menopause, a number of changes begin to occur. One of the most common is an increase in obesity, which, in turn, raises the risk for breast cancer after menopause.

9 Aug 2022

Mount Sinai receives $500,000 SU2C grant to identify therapeutic combinations for KRAS-mutant lung cancers

Mount Sinai is leading a team of lung cancer researchers that has been awarded a three-year, $500,000 grant from Stand Up To Cancer to explore therapeutic approaches to lung tumors with mutations in the KRAS gene, an undertaking that could have a significant impact for a large population of cancer patients who currently lack effective treatment options.

9 Aug 2022

Dual therapy offers both benefit and risk after common type of cardiac surgery

A new analysis shows that a combination of two anti-platelets drugs can benefit patients after the most common type of cardiac surgery - while also increasing the risk of potentially dangerous bleeding.

9 Aug 2022

Poor mental health during COVID-19 pandemic associated with weight gain in people with obesity

Over the first year of the COVID-19 pandemic, almost 30% of patients with obesity gained more than 5% of their body weight, and 1 in 7 gained more than 10%.

9 Aug 2022

Does loneliness affect the brain and heart?

Scientists review studies to determine the effects of social isolation and loneliness on brain health and cardiovascular conditions.

9 Aug 2022

Study details post-COVID-19 symptoms and conditions among children and adolescents in the US

In a new study, researchers assessed the incidence of post-COVID-19 symptoms and conditions among children and adolescents.

9 Aug 2022

Research projects the future mortality burden due to hot nights

Excessively hot nights caused by climate change are predicted to increase the mortality rate around the world by up to 60% by the end of the century, according to a new international study that features research from the UNC Gillings School of Global Public Health.

9 Aug 2022

Aldosterone may increase risk of kidney failure in patients with chronic kidney disease

A steroid hormone called aldosterone is linked to an increased risk of kidney failure in patients with chronic kidney disease (CKD), according to a study published in the European Heart Journal today (Tuesday).

8 Aug 2022

Exercise program improves physical functioning among older adults with chronic kidney disease

This randomized trial recently published in the American Journal of Kidney Diseases (AJKD) found that a 12- month program of in-center aerobic and resistance exercise program improved physical functioning among adults 55 years and older with CKD stages G3b-4 and a high level of medical comorbidities.

8 Aug 2022

Consolidation PD-(L)1 inhibition following concurrent chemoradiation for unresectable stage III NSCLC improves survival

Following concurrent chemoradiation for unresectable stage III non-small cell lung cancer, both nivolumab alone and nivolumab and ipilimumab combined demonstrated improved 18- month progression-free survival compared with historical controls despite a shortened interval (6 months) of treatment.

8 Aug 2022

Heart Disease News and Research

Latest Heart Disease News and Research

COVID-19 infection in pregnant women linked to increased risk of adverse outcomes

They call it ‘tranq’ — and it’s making street drugs even more dangerous

International medical experts aim to use biomarker-based approaches to advance precision medicine

How ultraprocessed foods affect gut microbiome and health

Older adults with atrial cardiopathy may have higher dementia risk

Scientists discover new target for treatment of premature aging disorders

Leisure activities may help lower the risk of dementia

Abnormal size or functioning in the heart's left atrium may increase dementia risk

Formulary restrictions may increase the risk of stroke in patients with atrial fibrillation

How common is chronic fatigue syndrome among patients with long COVID-19?

Study explores the role of follicle stimulating hormone in driving postmenopausal obesity, breast cancer

Mount Sinai receives $500,000 SU2C grant to identify therapeutic combinations for KRAS-mutant lung cancers

Dual therapy offers both benefit and risk after common type of cardiac surgery

Poor mental health during COVID-19 pandemic associated with weight gain in people with obesity

Does loneliness affect the brain and heart?

Study details post-COVID-19 symptoms and conditions among children and adolescents in the US

Research projects the future mortality burden due to hot nights

Aldosterone may increase risk of kidney failure in patients with chronic kidney disease

Exercise program improves physical functioning among older adults with chronic kidney disease

Consolidation PD-(L)1 inhibition following concurrent chemoradiation for unresectable stage III NSCLC improves survival

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Heart Disease News and Research

Latest Heart Disease News and Research

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Newsletters you may be interested in